Skip to main content

Table 1 General features of patients

From: Primary Sjögren syndrome and development of another autoimmune rheumatic disease during the follow-up

 

N = 681(100%)

Female gender n (%)

511 (94.8)

Age, mean (± SD)

54 (± 14)

Age at diagnosis, mean (± SD)

50 (± 13)

Follow up (years), mean (± SD)

4.7 (± 4.9)

Xeroftalmia n (%)

618/659 (93.78)

Xerostomia n (%)

581/672 (86.46)

Schirmer’s positive test n (%)

454/499 (90.98)

Decreased Unstimulated oral salivary flow n (%)

213/258 (82.56)

Rheumatoid Factor (RF) (+) n (%)

303/589 (51.34)

Anti Ro/SS-A (+) n (%)

467/627 (74.48)

Anti La/SS-B (+) n (%)

262/608 (43.09)

Positive biopsy n (%)

345/400 (86.25)

Salivary Gland Enlargement n (%)

186 (27.31)

Neuropathy n (%)

67 (9.84)

Arthralgia n (%)

436 (64.02)

Arthritis n (%)

191 (28.05)

Raynaud’s phenomenon n (%)

101 (14.83)